Drug intelligence / Profile preview

methylprednisolone + vitamin D3

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Topical, Ophthalmic, Inhalation
01

Overview

Methylprednisolone + vitamin D3 is a combination of two agents: - **Methylprednisolone** is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. It acts by binding to the glucocorticoid receptor, modulating gene expression to suppress pro-inflammatory cytokines and immune cell activity. It is used in the treatment of various autoimmune, inflammatory, allergic, respiratory, hematologic, neoplastic, dermatologic, gastrointestinal, ophthalmic disorders and more. - **Vitamin D3 (cholecalciferol)** is a fat-soluble secosteroid that enhances intestinal absorption of calcium and phosphate. It plays an essential role in bone health by promoting calcium homeostasis and has immunomodulatory effects via the vitamin D receptor (VDR). This combination may be considered for patients at risk of corticosteroid-induced osteoporosis or deficiency states; however, there are clinically significant interactions between these drugs. Methylprednisolone can reduce absorption/metabolism of vitamin D3 and decrease its efficacy; conversely, adequate supplementation with calcium/vitamin D may help prevent steroid-induced bone loss[1][2][7]. The interaction requires careful monitoring.

Other names
methylprednisolone and cholecalciferolmethylprednisolone and vitamin D3
02

Targets

GR (Glucocorticoid receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on methylprednisolone + vitamin D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylprednisolone + vitamin D3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call